Beyond Air, Inc.(XAIR)

Description: Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The Beyond Air NO Delivery System can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. The Company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections such as nontuberculous mycobacteria (NTM).

---

Keywords: Medicine Biopharmaceutical Hypertension Bacteriology Coronavirus Tuberculosis Pulmonary Hypertension Bacterial Disease Respiratory Tract Lung Infection Mycobacterium Nontuberculous Mycobacteria Respiratory Tract Infection Lower Respiratory Tract Infection Lung Infections Respiratory And Other Diseases

---

Home Page: www.beyondair.net

XAIR Technical Analysis

900 Stewart Avenue
Garden City, NY 11530
United States
Phone: 516 665 8200

---

Officers

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)